Routh, J. C., Vandersteen, D. R., Ashley, R. A., Inman, B. A., Reinberg, Y., Wolpert, J. J., … Husmann, D. A. (2007). 518: Routine Contralateral Deflux Injection in Patients with Unilateral Reflux: Increased Cost without Increased Efficacy? In Journal of Urology (Vol. 177, pp. 172–173). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1016/s0022-5347(18)30758-4

Routh, Jonathan C., David R. Vandersteen, Richard A. Ashley, Brant A. Inman, Yuri Reinberg, James J. Wolpert, Stephen A. Kramer, and Douglas A. Husmann. “518: Routine Contralateral Deflux Injection in Patients with Unilateral Reflux: Increased Cost without Increased Efficacy?” In Journal of Urology, 177:172–73. Ovid Technologies (Wolters Kluwer Health), 2007. https://doi.org/10.1016/s0022-5347(18)30758-4.

Routh JC, Vandersteen DR, Ashley RA, Inman BA, Reinberg Y, Wolpert JJ, et al. 518: Routine Contralateral Deflux Injection in Patients with Unilateral Reflux: Increased Cost without Increased Efficacy? In: Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2007. p. 172–3.

Routh, Jonathan C., et al. “518: Routine Contralateral Deflux Injection in Patients with Unilateral Reflux: Increased Cost without Increased Efficacy?” Journal of Urology, vol. 177, no. 4S, Ovid Technologies (Wolters Kluwer Health), 2007, pp. 172–73. Crossref, doi:10.1016/s0022-5347(18)30758-4.

Routh JC, Vandersteen DR, Ashley RA, Inman BA, Reinberg Y, Wolpert JJ, Kramer SA, Husmann DA. 518: Routine Contralateral Deflux Injection in Patients with Unilateral Reflux: Increased Cost without Increased Efficacy? Journal of Urology. Ovid Technologies (Wolters Kluwer Health); 2007. p. 172–173.